130 citations
,
February 2019 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” This study found that JAK inhibitors for alopecia areata showed promising response rates, with 72.4% of 289 cases responding, and oral administration achieving better outcomes than topical treatment, but recurrence occurred when treatment stopped. Further large-scale studies are needed to confirm these findings.
7 citations
,
January 2019 in “Headache” This source suggests that migraine prevalence increases in transgender women using oestrogen and decreases in transgender men using testosterone, with high oral oestrogen doses in transgender women potentially linked to aura risk.
August 2023 in “International journal of research in Ayurveda and pharmacy” This analysis explored Ayurveda's approach to addressing hair fall, emphasizing the use of herbs and lifestyle modifications for prevention and regrowth, and critically examined classical Ayurvedic concepts related to causation and treatment of hair loss.
October 2022 in “International Journal of Dermatology” In this study, patients using the digitally enabled platform Keeps for male pattern hair loss treatment reported positive health outcomes, with 81% experiencing hair regrowth or ceasing hair loss after six months.
September 2026 in “TURKDERM” This study found that various treatment combinations for folliculitis decalvans generally led to clinical improvement and hair regrowth in male patients, though relapse was common after treatment cessation.
